ExodusPoint Capital Management’s Evolent Health EVH Stock Holding History

ExodusPoint Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200,000	Closed	-$6.2M	–	2280
2021 Q3	$6.2M	Buy	+200,000	New	+$4.8M	0.08%	327

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

ExodusPoint Capital Management's EVH Position: Q2 2026 in Review

ExodusPoint Capital Management increased its Evolent Health (EVH) stake by 968% in Q2 2026, buying an estimated $556K and bringing the position to 159,986 shares worth $867K. The position accounts for 0.01% of the portfolio, ranked #1113.

ExodusPoint Capital Management first reported a position in EVH in Q2 2019 and has held it in 16 quarters since. The position peaked at $1.23M in Q2 2022. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

ExodusPoint Capital Management held 159,986 shares of Evolent Health worth $867K as of Q2 2026.
ExodusPoint Capital Management bought 145,003 Evolent Health shares in Q2 2026, an estimated $556K.
Evolent Health made up 0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #1113 holding.
ExodusPoint Capital Management first reported a position in Evolent Health in Q2 2019 and has held it in 16 quarters since.
ExodusPoint Capital Management's Evolent Health position peaked at $1.23M in Q2 2022.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.